Hematologic Oncology
Hematologic Oncology
Recently Added |View More
New Treatment for AML Led by Roswell Park Expert Earns FDA Approval
A clinical trial for an aggressive form of leukemia, devised and co-led by Eunice Wang, MD, Chief of Leukemia at Roswell Park Comprehensive Cancer Center, was recently approved by the FDA.
Featuring speakers from nationally recognized institutes from across the country and led by experts from Roswell Park Comprehensive Cancer Center, the Upstate New York Hematology & Hematologic Oncology Conference: A Review of the 67th ASH Annual meeting.
Miss Us at ASCO? Join Us for A Year in Review This September
Reflect on the latest research presented at this year’s ASCO conference and discuss what’s next at Roswell Park Oncology Year-In-Review, scheduled for Saturday, September 26 in Buffalo, NY.
New Trial for Rare Brain Lymphoma Open at Roswell Park
Roswell Park Comprehensive Cancer Center is one of four locations in the United States and Europe in which patients with relapsed or refractory non-Hodgkin lymphoma in their central nervous system can access a new clinical trial, led by ...
Join Roswell Park at AACR 2026
Roswell Park experts present updates on their latest groundbreaking research at the American Association for Cancer Research conference, April 17-22, 2026, in San Diego.
A clinical trial now recruiting at Roswell Park Comprehensive Cancer Center aims to redefine therapeutic stratification and improve outcomes for patients with extensive-stage small cell lung cancer (ES-SCLC).
New Phase I/II Trial Using Multimodal PDT for Advanced, Recurrent Colorectal Cancer
Long a pioneer in innovative treatments for colorectal cancer, Roswell Park Comprehensive Cancer Center is recruiting patients with locally advanced or recurring colorectal cancer for a new trial involving photodynamic therapy, a technology ...
Register Today for Roswell Park’s Upstate New York Hematology & Hematologic Oncology Conference
Register for the Upstate New York Hematology & Hematologic Oncology Conference: A Review of the 67th ASH Annual meeting, taking place on April 25-26 in Buffalo, NY.
A phase 1 clinical trial underway exclusively at Roswell Park Comprehensive Cancer Center in Buffalo, N.Y., is evaluating a new chimeric antigen receptor (CAR) T-cell therapy that could dramatically transform the treatment of relapsed ...
This site is intended for healthcare professionals
RPMD App
Access wherever you go
Click your preferred app store below to download our free mobile app — exclusively for physicians and physician offices — for direct access to a complete, up-to-date directory of Roswell Park physicians wherever you go. Email or call to refer a patient or ask a question with a click of a button.

